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Abstract Vertebrate Hox genes act as developmental
architects by patterning embryonic structures like axial
skeletal elements, limbs, brainstem territories, or neural
crest derivatives. While active during the patterning
steps of development, these genes turn out to be down-
regulated in specific differentiation programs like that
leading to chondrogenesis. To investigate why chon-
drocyte differentiation is correlated to the silencing of a
Hox gene, we generated transgenic mice allowing Cre-
mediated conditional misexpression of Hoxa2 and
induced this gene in Collagen 2 alpha 1-expressing cells
committed to enter chondrogenesis. Persistent Hoxa2
expression in chondrogenic cells resulted in overall
chondrodysplasia with delayed cartilage hypertrophy,
mineralization, and ossification but without prolifera-
tion defects. The absence of skeletal patterning anomaly
and the regular migration of precursor cells indicated
that the condensation step of chondrogenesis was
normal. In contrast, closer examination at the differ-
entiation step showed severely impaired chondrocyte
differentiation. In addition, this inhibition affected
structures independently of their embryonic origin. In
conclusion, for the first time here, by a cell-type specific
misexpression, we precisely uncoupled the patterning
function of Hoxa2 from its involvement in regulating
differentiation programs per se and demonstrate that
Hoxa2 displays an anti-chondrogenic activity that is
distinct from its patterning function.
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Introduction
The vertebrate skeleton is a composite organ consti-
tuted of limited membranous structures arising by
direct differentiation of mesenchyme into bone and a
majority of endochondral elements formed from a
preliminary cartilaginous anlage. According to the
precursor tissue, one can distinguish the appendicular
skeleton, which derives from lateral mesoderm, the axial
skeleton, originating from paraxial mesoderm, and the
cephalic skeleton, essentially derived from the neural
crest (NC) cells (Couly et al., 1993; Lengelé et al., 1996;
Christ et al., 2000; Santagati and Rijli, 2003). These
precursors are of distinct embryonic origin as paraxial
and lateral mesoderm both arise from a primitive
mesodermal layer, whereas NC cells spread out from
neural ectoderm to give the so-called ectomesenchyme.
After mesenchymal transformation of the sclero-
tome, budding of limb mesenchyme, or sprouting of
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skeletogenic NC cells, chondrogenic condensation
occurs. This process is initiated by the migration and
aggregation of precursor cells under the influence of
fibroblast growth factors (FGFs) and bone morpho-
genic proteins (BMPs). The precise shape and location
of condensations are mostly defined by the expression
pattern of homeotic (Hox) genes (Christ et al., 2000).
Condensation also requires Pax1 and Pax9 gene
products that allow precursor cells to respond to
inductive signals such as Sonic Hedgehog (Shh) and
prevent them from either apoptosis or premature
differentiation (Peters et al., 1999). Recently, Pax1 and
-9 have been shown to be required for the activation of
Nkx-3.2 (Bapx1), a Shh-induced factor, which in turn
activates the chondrogenic marker Sox9 (Zeng et al.,
2002; Rodrigo et al., 2003). The critical activation of
Sox9 then marks the onset of chondrogenic differentia-
tion. Indeed, if Sox9 is inactivated after the condensation
step, cartilage fails to develop (Akiyama et al., 2002).
Once at the right place, condensations grow and cells
differentiate to become proliferating chondrocytes.
While the proliferation of precursor cells is notably
controlled by factors of the retinoblastoma (Rb) family,
namely p107 and p130 (Rossi et al., 2002), chondrocytic
differentiation still depends upon FGF (Murakami
et al., 2000), BMP (Wan et al., 2001), as well as on
ephrins (Stadler et al., 2001) and many other factors
(Hoffmann et al., 2002; Scheijen et al., 2003). Further to
their proliferation, chondrocytes become hypertrophic,
cartilage undergoes mineralization, is resorbed, and
replaced by bone. Here again, Sox9, but also the Wnt,
Indian Hedgehog, and parathyroid hormone signaling
cascades, coordinate these maturation steps (Yang
et al., 2003).
Hox homeotic genes are well-known patterning genes
that confer identity to skeletogenic condensations
(Krumlauf, 1994). These genes are globally expressed
in condensing cells but are turned off as differentiation
starts. Hoxa2, the most anteriorly expressed Hox gene,
contributes to the specification of the second branchial
arch (BA2). Indeed, Hoxa2 inactivation results in the
homeotic transformation of BA2, which therefore gives
rise to the mirror duplication of BA1 structures
(Gendron-Maguire et al., 1993; Rijli et al., 1993).
Conversely, ectopic expression of Hoxa2 in the first
BA of fish, frog, and chick leads to the reverse
transformation (Grammatopoulos et al., 2000; Pasqua-
letti et al., 2000; Hunter and Prince, 2002). The
homeotic transformation of BA2 in Hoxa2 knock-out
(KO) mice is paralleled by the activation of the BA1-
specific markers Ptx1 and Lhx6. In addition, the
phenotype of the Hoxa2 KO is partially rescued in
Hoxa2/Ptx1 double KO. It was thus proposed that
Hoxa2 confers the BA2 fate by restricting Ptx1 and
Lhx6 expression domains anteriorly to BA2 in wild-type
(WT) embryos. As Ptx1 and Lhx6 activation in BA1 is
under the control of FGFs, Hoxa2 activity was
suggested to interfere at some point with the FGF
signaling cascade (Bobola et al., 2003).
While previous studies on Hoxa2 function basically
addressed its roles in the patterning of embryonic
structures, the link between Hoxa2 activity and
differentiation programs per se remains elusive. In
particular, the reason why, once properly located and
specified, cartilage precursors turn their Hox genes off
remains unclear. Interestingly, Sox9 and Cbfa1 expres-
sion domains have been reported to be extended in
Hoxa2 KO mice (Kanzler et al., 1998). As these genes
are well-known chondro- and osteogenic lineage mar-
kers, this phenomenon was first interpreted as the loss
of a putative Hoxa2 anti-skeletogenic activity in the
BA2 area. However, in both the Hoxa2 KO and Hoxa2
ectopic expression experiments (Grammatopoulos
et al., 2000; Pasqualetti et al., 2000), it was not possible
to discriminate whether the phenotypic alterations were
imputable to the involvement of Hoxa2 in the pattern-
ing of developing structures or to its possible effect on
differentiation programs of cartilage and bone per se.
To investigate specifically why Hoxa2 needs to be
switched off by the onset of chondrocyte differentiation,
we analyzed the impact of a sustainedHoxa2 activity on
cartilage development. In that respect, we generated
transgenic mouse lines allowing Cre-mediated Hoxa2
induction and we crossed these lines with mice bearing a
Cre recombinase gene under the control of the cartilage-
specific Col2a1 promoter (Ovchinnikov et al., 2000).
Thereby, we caused Hoxa2 expression to persist beyond
the onset of chondrocyte differentiation, i.e., beyond
that precise stage it should be turned off, and to extend
to larger territories than its normal sphere of action.
Induced mice display delayed cartilage development
and severe chondrodysplasia. Histological characteriza-
tion of developing cartilaginous elements in these mice
further demonstrates that Hoxa2 activity impairs
chondrogenesis from its earliest steps. As this down-
regulatory effect is exerted after the condensation step,
we propose that it is independent of the patterning
function of Hoxa2 but rather results from the inter-
ference with a common basic chondrogenic program.
Methods
Plasmid constructs
The transgene for the conditional expression of Hoxa2 was
obtained as follows: a Hoxa2 genomic fragment spanning 47 bp
of the 50 untranslated region (UTR) plus the entire coding sequence
was inserted downstream of a 4.3 kbp EcoRI-AluI fragment of the
human b-actin promoter including the first intron (IVS1) of the
gene (Leavitt et al., 1984; Fig. 1A). This fragment was cloned
upstream of a 4.4 kbp reporter cassette. The reporter cassette
contains a 1.1 kbp internal ribosome entry site (IRES) from
Theiler’s virus (Shaw-Jackson and Michiels, 1999) fused to a
nuclear localizing sequence (NLS)-tagged Escherichia coli lacZ gene
and followed by the SV40 late region polyadenylation signal. A
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loxP-flanked cassette to arrest transcription (STOP) was inserted
between the b-actin promoter and Hoxa2 sequence. The stopping
cassette was obtained from pBS302 (Invitrogen, Carlsbad, CA)
after addition of a neomycin resistance gene (Kellendonk et al.,
1996) to a unique BglII site. Introduction of the stopping cassette
into the transgene was performed in vitro, using the Cre-
recombinase system (Clontech, Mountain View, CA; construct
details available upon request).
Generating and maintenance of transgenic mice
SpeI and/or SfiI linearized transgenes were microinjected into the
male pronucleus of inbred FVB zygotes and transferred into C57Bl/
6C3h F1 foster mice at E0.5. Transgenics were identified by
polymerase chain reaction (PCR) screening using specific primers for
‘‘fragment 2’’ (Figs. 1A,1B). Transgenics were mated with mice for a
collagen IIa1 promoter-directed Cre-expression (Col2a1-Cre; Ov-
chinnikov et al., 2000). Col2a1-Cre and Col2a1/Hoxa2-lacZ simple
and double transgenics were mated with R26R mice (Soriano, 1999)
for Cre-activity detection. Excision of the STOP cassette was assayed
with PCR primers for ‘‘fragment 1’’ (Figs. 1A,1B).
Western blotting
To evaluate the level of Hoxa2 expression upon Cre-mediated
induction, E13.5 embryos were collected and individually processed
for whole protein extraction. Thirty micrograms of each protein
extract, as estimated by the Pierce bicinchoninic acid protein assay
kit (Pierce Biotechnology Inc., Rockford, IL), were run on sodium
dodecyl sulfate-polyacryilamide gel electrophoresis and transferred
to a nitrocellulose membrane. Immuno-detection of Hoxa2 was
performed with the goat polyclonal anti-Hoxa2 antibody (N-20,
sc17149; Santa Cruz Biotechnology Inc., Santa Cruz, CA) at a
1:20,000 dilution, followed by a secondary reaction with the
peroxidase-coupled anti-goat immunoglobulin (IgG; PI-9500;
Vector Laboratories, Burlingame, CA) used at 1:200. Detection
of b-actin involved the rabbit anti-actin (20–33) antibody (A5060;
Sigma, Bornem, Belgium) at 1:8,000 and the biotinylated anti-
rabbit IgG (BA-1000; Vector) at 1:200 as a secondary antibody.
Western blots were revealed by chemo-luminescent reactions
(Pierce Supersignal West Pico trial kit) and scanned for quantifica-
tion of detected proteins (EPSON Perfection 4990 Photo; data
treatment with Image J v1.345 software). A semi-quantitative
estimate of the level of Hoxa2 expression was obtained by
comparison with the level of b-actin expression.
Whole-mount staining
For bone and cartilage staining, after removal of the skin and
internal organs, embryos were fixed overnight in 95% ethanol,
stained with 0.02% alcian blue in 4:1 95% ethanol:acetic acid for 2
days, washed in 95% ethanol, immersed in 2% KOH for 18 hr,
stained in 75mg/ml alizarin red in 1% KOH overnight, processed
through a graded series of glycerol in ethanol and stored in 100%
glycerol.
For cartilage staining, E13.5 embryos were fixed overnight in
Bouin’s solution, rinsed briefly with water, immersed for at least 1 hr
in four changes of 1% ammonia in 70% ethanol, and stained with
0.05% alcian blue in 5% acetic acid. Embryos were rinsed three
times in 5% acetic acid for 1–2 hr each and then once overnight.
Specimens were dehydrated through graded ethanols, cleared, and
stored in 2:1 benzyl alcohol:benzyl benzoate (BA:BB; Sigma).
For b-galactosidase activity detection (X-Gal staining), embryos
harvested from E9.5 to 15.5 were fixed up to 60min in 4%
paraformaldehyde (PFA) and washed in 0.01% sodium deoxycho-
late, 0.02% NP-40 in phosphate-buffered saline (PBS; pH 7.4).
Specimens were then stained overnight at room temperature in
washing buffer containing 1mg/ml X-gal (Sigma), 5mM potassium
ferrocyanide, 5mM potassium ferricyanide, and 2mM MgCl2.
Samples were subsequently rinsed, post-fixed in 4% PFA for 15 hr,
dehydrated, and eventually processed through histology or cleared
in BA:BB.
Histology and immunohistochemistry
Most embryos were fixed overnight in 4% PFA in PBS before
embedding in paraffin. They were cut into 5-mm-thick sections that
were stained with hematoxylin, alcian blue-nuclear fast red, or
according to Von Kossa’s procedure.
Immunohistochemical detection of type-X collagen, proliferating
cell nuclear antigen (PCNA), Hoxa2, Fgfr3, and Sox9 was
performed with rabbit anti-collagen X (Calbiochem), anti-PCNA
(Santa Cruz), anti-Hoxa2 (kindly provided by A. Nazarali), anti-
Fgfr3 (Santa Cruz), and anti-Sox9 (Sigma) as primary antibodies,
respectively. Immunoperoxidase staining was carried out using the
Envision1 kit (Dako, Glostrup, Denmark). Endogenous perox-
idase was blocked with 0.03% hydrogen peroxide for 5min. After
three washes in distilled water, type-X collagen antigen was
unmasked by 3-min microwave treatment in citrate buffer
(10mM, pH 6.0) and hyaluronidase from bovine testes (2mg/ml
in PBS, pH 7.0, Sigma) at room temperature. Unmasking of PCNA
was performed by 10min microwave treatment. Thereafter, the
nonspecific antigenic sites were neutralized by 10% normal goat
serum (NGS) in PBS for 30min. The sections were then incubated
overnight at 41C with the primary antibody (anti-collagen X, 1:400;
anti-PCNA, 1:200; anti-Hoxa2, 1:800; anti-Fgfr3, 1:500; and anti-
Sox9, 5 mg/ml). Then, they were washed twice in PBS and incubated
with secondary goat anti-rabbit antibody conjugated with a
peroxidase-labeled polymer. After three changes in PBS, peroxidase
was revealed by the diaminobenzidine reaction. The sections were
counterstained with hemalun or alcian blue-nuclear fast red,
dehydrated, and finally mounted. Control experiments included
omission of the first antibody. PCNA-positive cells were counted in
microscopic fields delimited by two successive intervertebral disks.
Bone mineral density (BMD) determination
Under anesthesia (Drobac et al., 2004), six Col2a1/Hoxa2-lacZ and
six bS-Hoxa2-lacZ mice were scanned with a peripheral quantita-
tive computed tomography (pQCT) XCT Research SA1 (Stratec
Medizintechnik GmbH, Pforzhein, Germany) 1 day after birth. The
Col2a1/Hoxa2-lacZ mice were scanned a second time after death,
the bS-Hoxa2-lacZ mice after sacrifice at the equivalent time. Three
500-mm-thick midsagittal and paramedian sagittal slices spaced out
of 250 mm were selected from a scout view image. The total scan
lasted about 15min. The voxel size was 70mm. Images were
analyzed with the XCT540 software provided with the pQCT. A
0.044mm2 region of interest (ROI) was selected in the third cervical
(C3), sixth thoracic (C6), and fourth lumbal (L4) vertebrae on the
best slice of each mouse. BMD ( mg HAP/cm3) was measured for
each ROI. The heights of three contiguous vertebrae of the cervical
(C2, C3, C4), thoracic (T5, T6, T7), and lumbal (L3, L4, L5)
regions were also measured with the software.
Results
Sustained Hoxa2 expression from the onset of
chondrocyte differentiation results in a severe
chondrodysplasia
To investigate why Hoxa2 needs to be silenced once
chondrocyte differentiation goes on, a binary Cre-loxP
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recombination system was used to generate conditional
Hoxa2 expression in developing cartilage. We produced
a construct that consists in theHoxa2 genomic sequence
placed under the control of the human b-actin promoter
and translationally coupled to a lacZ reporter by an
IRES. This construct was further modified by inserting
a ‘‘floxed’’ cassette blocking transcription between the
b-actin promoter and the Hoxa2 coding sequence, to
give rise to a silent hb-actin-STOP-Hoxa2-IRES-lacZ
transgene (bS-Hoxa2-lacZ for simplification, Fig. 1A).
Cell transfection assays, followed by b-galactosidase
activity detection demonstrated that the construct was
correctly expressed in the absence of the blocking
cassette. In addition, transgene expression upon co-
transfection experiments resulted in specific transactiva-
tion of known target reporters, providing evidence that
an active Hoxa2 protein was expressed from the
construct (data not shown).
The resulting bS-Hoxa2-lacZ transgene was micro-
injected into mouse zygotes and transgenic progeny was
identified by PCR. Among eight transgenic founders,
two were retained and mated with a heterozygous
Col2a1-Cre strain that drives Cre-expression in differ-
entiating chondrocytes (Ovchinnikov et al., 2000). As
strikingly similar skeletal phenotypes were observed in
the progenies of both founders, the derived lines will be
indistinctly discussed hereafter. In these bS-Hoxa2-lacZ
transgenic lines, Cre-mediated excision of the blocking
cassette was confirmed by PCR (Fig. 1B). To ensure
that the Hoxa2 protein was expressed upon inductive
crossings, E13.5 embryos were collected and processed
for whole-protein extraction and Western blotting.
Extracts obtained from embryos bearing both the bS-
Hoxa2-lacZ and Col2a1-Cre transgenes gave rise to a
Hoxa2-specific signal (Fig. 1C). In contrast, Hoxa2
expression was not detected in extracts obtained from
WT or simple transgenic embryos. A semi-quantitative
estimate of the Hoxa2 protein revealed that the relative
expression of Hoxa2 varied by less than a factor two
among double transgenic individuals (data not shown).
Upon mating with Col2a1-Cremice, about one-fourth
of the resulting double transgenics (Col2a1/Hoxa2-lacZ
for simplification) died within the first few hours of life
(17.5% of double transgenics at birth versus 25% at
E18.5; Table 1). They presented a crumpled skin with a
kinked tail, a shortened snout, and frequent palatal
clefts (Fig. 1D). Another quarter of the double
transgenic littermates showed important growth retar-
dation (Fig. 1E) and died within a few weeks. Finally,
less than two-thirds of the double transgenics were
viable, although mildly dwarf or malformed (15.5% of
double transgenics at 12 weeks post partum, Table 1).
X-gal staining of E13.5 double transgenics confirmed
specific transgene activation into a large set of devel-
oping cartilages (Figs. 2A,2B). E. Coli b-galactosidase
activity was detected all along the axial skeleton, from
the proximal Meckel’s cartilage and otic capsule to the
tail tip. Rib processes and limbs were also clearly
stained with an intense signal in limb joints. The
strongest signal was detected in the cervico-occipital
and proximal Meckel’s cartilage regions. Unexpectedly,
Cre-recombinase also appeared to induce the bS-
Hoxa2-lacZ transgene into the whole body dermis from
E15 onwards (data not shown), which could account for
skin abnormalities in double-mutant newborns.
Skeletons of E18 fetuses (nine double Col2a1/Hoxa2-
lacZ, five WT and five bS-Hoxa2-lacZ transgenics) and
neonates (11 double Col2a1/Hoxa2-lacZ, five WT and
five bS-Hoxa2-lacZ transgenics) were analyzed by
differential staining of bones and cartilages. A global
hypoplasia of both axial and appendicular elements was
observed in all Col2a1/Hoxa2-lacZ mutants, while
simple bS-Hoxa2-lacZ transgenics were indistinguish-
able from WT littermates (Figs. 3A,3G). Col2a1/
Hoxa2-lacZ double transgenics displayed an overall
Fig. 1 Transgenic mice for the Col2a1-Cre-induced expression of
Hoxa2. (A) The transgene is composed of the Hoxa2 genomic
sequence under the transcriptional control of the human b-actin
promoter and followed by the internal ribosome entry site (IRES)–
nuclear localizing sequence (NLS)-lacZ reporter sequence. A floxed
cassette for transcriptional arrest (STOP) was inserted between the
promoter and the Hoxa2 coding region. (B) Polymerase chain
reaction (PCR) screening at the junctions between IRES and lacZ
yields fragment ‘‘2,’’ and allows detection of transgenic individuals.
PCR with primers specific of the promoter and Hoxa2 sequences
gives rise to fragment ‘‘1,’’ when the STOP cassette has been
removed by Cre-mediated recombination. (C) Western blotting of
whole-protein extracts from E13.5 Col2a1/Hoxa2-lacZ double
transgenic embryos reveals Hoxa2 expression (lanes 1–4), while
simple transgenics do not express Hoxa2 at a detectable level (lane
5). (D) At birth, the mostly affected transgenics for both Col2a1-Cre
and bS-Hoxa2-lacZ transgenes die and show a crumpled skin with
a shortened snout. (E) At 5 weeks, the mildly affected double
transgenics show severe growth retardation.
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less intense cartilage staining and a reduced axial length.
The vertebral column curvature was flattened with
cervical lordosis (arrowhead) and Spina bifida (arrow).
The number of vertebrae and ribs was normal (Figs.
3B,3H), but ossification of the vertebral bodies
appeared delayed, particularly in the cervical spine
(arrowhead). The limbs were never malformed but
slightly reduced in size and the ossification of the
autopod was always delayed (Figs. 3C,3I). The skull
presented either a reduced size or a brachycephaly
(Figs. 3D,3J). With regard to paraxial mesoderm
derivatives, the supraoccipital was rarely formed. The
neural arches, vertebral bodies, basisphenoid, basiocci-
pital, and exoccipital were always severely reduced
(Table 2; Figs. 3D,3J). Interestingly, the malformed
vertebral bodies were often fused to the neural arches
(Figs. 3B,3H), and, in a similar way, the basioccipital
was frequently joined to the exoccipitals (Figs. 3D,3J).
Concerning the NC derivatives, the basihyoid, otic
capsule (of dual origin), and middle-ear ossicles were
reduced or poorly ossified but never malformed (Figs.
3E,3K). Meckel’s cartilage was reduced, absent (Figs.
3E,3K), or sometimes split in its proximal part. The
nasal capsule, pterygoid, tympanic, and presphenoid
bones were also clearly reduced. In some cases, the
palatine bones were so dramatically reduced that the
presphenoid was apparent (Table 2 and Figs. 3F,3L).
The laryngeal and tracheal cartilages, the sternum,
xiphoid process, and clavicles were normal, although
slightly smaller. Most membranous bones of the face
were also reduced so that actually all the examined
skeletal structures appeared affected.
Col2a1-expressing chondrogenic precursors are
normally abundant and distributed
No homeosis was expected to be observed in Col2a1/
Hoxa2-lacZ transgenics as only the differentiation step
was targeted. Consistently, although clearly hypoplastic
or locally interrupted, the proximal Meckel’s cartilage
and middle-ear ossicles appeared normally shaped in
these pups. To further exclude any major patterning
defect as a possible cause of the observed Col2a1/
Hoxa2-lacZ mutant phenotype, we verified that chon-
drogenic precursor cells were normally distributed in
the presence of both transgenes.
The R26R reporter mouse is a strain that has been
engineered to allow the early detection of Cre recombi-
nase activity in tissues through lacZ conditional
expression (Soriano, 1999). Crossing the Col2a1-Cre
transgene in the R26R background therefore allowed
the detection of the Col2a1-expressing chondrogenic
precursors. We further brought together the three
transgenes (bS-Hoxa2-lacZ, Col2a1-Cre, and R26R) in
the same pups and compared the distribution of
precursor cells with that observed in controls (Col2a1-
Cre/R26R). Patterning defects or massive cell death
arising upon Hoxa2 induction should display an altered
abundance or distribution of Col2a1-Cre-expressing
cells in the presence of the bS-Hoxa2-lacZ transgene.
Embryos were harvested at E10.5, when progenitor cells
migrate from the somites and condense. At this stage,
these cells express Col2a1-Cre, as reported by Ovchin-
nikov et al. (2000). No obvious difference in stained
cells’ distribution was found between Col2a1/Hoxa2-
lacZ (n5 3) and Col2a1-Cre (n5 3) transgenic embryos
in the R26R background (Figs. 4A,4B), indicating that
cells were equally abundant and similarly patterned in
the presence or absence of the Hoxa2-inducible
transgene. To exclude the possibility that the similar
precursor cell distribution in these embryos reflects a
low penetrance of the skeletal phenotype in the R26R
genetic background, we looked at the skeletons of E18
fetuses in the progeny of identical crosses. Col2a1/
Hoxa2-lacZ double transgenics in the R26R back-
ground (n5 7) showed exactly the same malformations
at the same frequency as those reported in Table 2.
These data therefore demonstrate that the phenotype
resulting from the Col2a1-Cre-mediated induction of
Hoxa2 is not due to late patterning defects or massive
cell death.
Table 1 Proportion of Col2a1/Hoxa2-lacZ mice at different devel-
opmental and postnatal stages in Col2a1-Cre bS-Hoxa2-lacZ
progenies
Age Animals (litters) Col2a1/Hoxa2-lacZ (%)
E13.5 111 (10) 27 (24.3)
E18.5 140 (12) 36 (25.7)
Newborn 114 (10) 20 (17.5)
6 weeks 76 (7) 12 (15.8)
12 weeks 71 (7) 11 (15.5)
Fig. 2 X-gal staining of E13.5 Col2a1/Hoxa2-lacZ transgenics
shows transgene expression in differentiating cartilages. b-galacto-
sidase activity is detected (A) in forelimbs (FL), hindlimbs (HL),
otic capsules (black arrow), as well as (B) in the whole vertebral
column (black arrowhead), skull base, in the region of proximal
Meckel (open arrow) and in differentiating ribs (white arrowhead;
scale bar5 0.5mm).
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Overall cartilage maturation defects upon persistent
Hoxa2 expression
To unravel the cause of the observed skeletal defects,
each maturation step of skeletogenesis was addressed in
Col2a1/Hoxa2-lacZ mutants. Histological and immu-
no-histochemical examination was carried out on
Col2a1/Hoxa2-lacZ and bS-Hoxa2-lacZ or WT E15.5
fetuses. At this developmental stage, proliferative,
hypertrophic, mineralized, and ossified cartilages are
visible in normal pups. In WT (n5 5) and bS-Hoxa2-
lacZ fetuses (n5 4), bones and cartilage appeared well
developed. In contrast, Col2a1/Hoxa2-lacZ mutants
(n5 7) showed chaotic cartilages organization with
smaller differentiated hypertrophic areas (Figs.
4C,4D). Their vertebral column looked about half the
normal size and spinous processes were hypoplastic or
even absent. At E15.5, chondrocyte proliferation was
examined through PCNA immunostaining. In both bS-
Hoxa2-lacZ (n5 3) and Col2a1/Hoxa2-lacZ (n5 3)
spines, proliferating cells were localized at the vertebral
bodies periphery with a higher density around inter-
vertebral disks (Figs. 4E,4F). No difference in prolifer-
ating cells number or localization was seen between
simple- and double-mutant mice (Fig. 4G). The
maturation of the hypertrophic cartilage was assessed
by type-X collagen immunostaining. While an expected
strong signal was precisely detected in the vertebral
bodies centrum of WT (n5 2) and bS-Hoxa2-lacZ
(n5 3) pups, it appeared milder and dispersed in double
transgenics (n5 3; Figs. 4H,4I). Finally, cartilage
mineralization, emphasized by Von Kossa’s/AR stain-
ing, was clearly delayed in double transgenics (n5 3)
as compared with control pups (n5 3). It was even
practically absent in the basihyoid (Figs. 4J,4K). All
these observations were also noticed for double-mutant
Fig. 3 Alcian blue and Alizarin red stain-
ing of Col2a1/Hoxa2-LacZ and bS-
Hoxa2-lacZ skeletons. (A,G) Differential
staining of bones and cartilages reveals
severe cervical lordosis (arrowhead) in
newborn double mutants with spina
bifida (arrow), and significant reduction
of the cervical column, especially at the
level of the atlas (A; scale bars5 5mm).
(B,H) bS-Hoxa2-lacZ (B) and Col2a1/
Hoxa2-LacZ (H) spines indicating global
chondrodysplasia with aberrant shape of
the vertebral bodies (VB) and reduced or
absent ossification centers in Col2a1/
Hoxa2-LacZ mutants (arrowheads; scale
bars5 1mm). (C,I) bS-Hoxa2-lacZ (C)
and Col2a1/Hoxa2-LacZ (I) forelimbs
showing size reduction in double-mutant
limbs with delayed autopod ossification
(arrow; 1mm scale). (D,E,F,J,K,L) bS-
Hoxa2-lacZ (D,E,F) and Col2a1/Hoxa2-
LacZ (J,K,L) skull bases and otic cap-
sules (scale bars5 1mm). In the Col2a1/
Hoxa2-LacZ mutants, the basioccipital
(BO) is reduced and/or fused (arrows) to
the exoccipitals (EO). The basi- (BS) and
the presphenoid (PS) are reduced as well
as the pterygoid (Pt) and palatine bones
(P), which are largely hypoplastic. The
Meckel (Mk) is absent. Otic capsule (OC)
shows an ossification delay, but is not
malformed, like the tympanic ring (TR).
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limbs and ribs, although they were less pronounced.
In conclusion, while the proliferation of chondrocytes
did not appear to be affected by a persistent Hoxa2
expression, the whole cartilaginous maturation
process appeared impaired in Col2a1/Hoxa2-lacZ mice.
In addition, Hoxa2 misregulation equally affected
skeletal derivatives of either NC or mesoderm origin.
Hoxa2 expression in chondrogenic precursors impairs
the initial differentiation steps
Whether the above-mentioned maturation defects could
be related to an initial differentiation failure in Col2a1/
Hoxa2-lacZ mice remained to be addressed. To
investigate on this issue, whole-mount double-mutant
skeletons were examined at E13.5. At this stage,
chondrocyte differentiation has progressed and hyper-
trophy has just begun in normal mice. Surviving
Col2a1/Hoxa2-lacZ mice were thus mated together
and embryos were collected. One resulting litter was
genotyped and processed for alcian blue staining.
Consistent with a mendelian distribution, 6/13 embryos
were negative for at least one of the transgenes (bS-
Hoxa2-lacZ or Col2a1-Cre). Those embryos presented a
normal skeletal development, particularly in the verteb-
Table 2 Hypoplastic structures in Col2a1/Hoxa2-lacZ mutant
neonates
Affected structures Embryonic origin
Nasal cartilage Neural crest
Presphenoid Neural crest
Basisphenoid Paraxial (somitic) mesoderm
Basioccipital Paraxial (somitic) mesoderm
Exoccipital Paraxial (somitomeric) mesoderm
Supraoccipital Paraxial (somitomeric) mesoderm
Otic capsule Paraxial mesoderm1Neural crest
Incus and malleus Neural crest (BA1)
Tympanic ring Neural crest (BA1)
Pterygoid Neural crest (BA1)
Palatine Neural crest (BA1)
Meckel’s cartilage Neural crest (BA1)
Stapes Neural crest (BA2)
Body of the hyoid Neural crest (BA2)
Vertebrae Paraxial (somitic) mesoderm
Ribs Paraxial (somitic) mesoderm
Limbs Lateral mesoderm
Fig. 4 Histological comparison between Col2a1/Hoxa2-lacZ dou-
ble transgenics and Col2a1-Cre littermates in the R26R1/
background at E10.5 (A,B), and histological and immunohisto-
chemical comparison of Col2a1/Hoxa2-lacZ mutants with bS-
Hoxa2-lacZ littermates at E15.5 (C–K). In each case, bS-Hoxa2-
lacZ transgenics showed the same phenotype as wild-type
littermates. (A,B) X-Gal-stained transverse section of E10.5
embryos. Cre-expressing cell distribution (blue staining indicated
by the arrow) in double Col2a1-Cre/R26R transgenics (Col2a1/
R26R for simplification; A) and triple Col2a1-Cre/bS-Hoxa2-lacZ/
R26R transgenics (Col2a1/Hoxa2/R26R for simplification; B),
shows no difference between double mutants and control litter-
mates. Neural tube (N), spinal ganglion (SG). (C,D) At E15.5, AR
staining of a sagittal section in the lumbal column of bS-Hoxa2-
lacZ (C) and Col2a1/Hoxa2-lacZ (D) transgenics. Vertebral body
(VB; E,F,G) proliferating cells staining (E,F) and counting (G) via
proliferating cell nuclear antigen (PCNA) immuno-detection in
sagittal sections through cervical column of bS-Hoxa2-lacZ (E) and
Col2a1/Hoxa2-lacZ (F) transgenics. No significant difference was
detected in proliferating cells number or localization between
control and Col2a1/Hoxa2-LacZ mutant littermates. Each value
shown in (G) is the mean counted positive cells for three
independent pairs of embryos. (H,I) At E15.5, anti-collagen X
immunostaining on similar sections shows clear localization of
collagen X in hypertrophic chondrocytes (HC) of vertebral bodies
in bS-Hoxa2-lacZ transgenics (H) but fainter and less organized
staining in Col2a1/Hoxa2-lacZ mutant (I). Proliferating chondro-
cytes (PC). (J,K) At E15.5, Von Kossa/AR staining of the
basihyoid (BH) in bS-Hoxa2-lacZ (J) and Col2a1/Hoxa2-lacZ
(K) transgenics showing a significant mineralization delay in double
mutants compared with control pups (arrow). Scale bars5 200 mm.
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ral column, ribs, basihyoid, otic capsule, and Meckel’s
cartilage (Figs. 5A,5C,5E). Conversely, the most
affected double mutants (2/13) displayed almost no
axial skeleton but rudiments of basioccipital, exoccipi-
tal, atlas, and distal ribs (Figs. 5B,5D). The Meckel’s
cartilage was occasionally split in its proximal part (Fig.
5F) and sometimes, the basihyoid was not yet differ-
entiated. The remaining progeny (5/13) showed an
intermediate phenotype.
When looking at the X-gal staining intensity in E13.5
litters, the embryos showing the highest staining also
displayed the most affected structures (data not shown).
This correlation is suggestive of a gene dosage effect on
the expressivity of the phenotype, which would explain
the occurrence of a low number of more severely
affected embryos interpreted as homozygous for the
induced bS-Hoxa2-lacZ transgene. This could also
explain the apparent co-localization of Meckel’s carti-
lage splitting point with an intense X-gal staining spot
(compare Figs. 2B,5F). In contrast, staining was never
detected in some rostral-affected structures like the
presphenoid or the nasal capsule, which might display a
higher sensitivity to Hoxa2 misexpression.
To further delineate the impact of the sustained
Hoxa2 expression on the chondrogenic cascade, we
looked at the expression of two of the earliest
chondrogenic determinants, FGF receptor 3 (Fgfr3)
and Sox9. Fgfr3 and Sox9 are both expressed at the
very onset of differentiation and their expression
persists up to the prehypertrophic stage. As Fgfr3
indirectly stimulates the expression of Sox9 (Murakami
et al., 2000), an alteration in their relative expression
domains would mean that Hoxa2 interferes at some
point within this cascade in Col2a1/Hoxa2-lacZ mice.
As expected, Hoxa2 was only detected in the vertebral
column of Col2a1/Hoxa2-lacZ mutants. This staining
was prominently found in undifferentiated cells lying at
the periphery of restricted developing cartilages (Figs.
6A–6C). In both WT (n5 2) and bS-Hoxa2-lacZ (n5 2)
E13.5 embryos, strong immunostaining signals for Sox9
and Fgfr3 were observed in differentiating vertebral
bodies (Figs. 6D,6F). Strikingly, upon Hoxa2 induc-
Fig. 5 Skeleton analysis of Col2a1/Hoxa2-lacZ and bS-Hoxa2-lacZ
littermates at E13.5 by alcian blue staining of the whole cartilages.
(A,B) Lateral view of bS-Hoxa2-lacZ (A) and Col2a1/Hoxa2-LacZ
(B) transgenics showing exoccipitals (arrow) and cervical hypopla-
sia and no differentiation of the rest of the vertebral column
(arrowhead). (C,D) Dorsal view of bS-Hoxa2-lacZ (C) and Col2a1/
Hoxa2-LacZ (D) transgenics showing otic capsule (arrow) and
Meckel (white arrowhead) hypoplasia and nearly no axial skeleton
but distal ribs rudiments (black arrowhead). (E,F) Magnification of
Meckel’s (Mk) region in bS-Hoxa2-lacZ (E) and Col2a1/Hoxa2-
lacZ (F) transgenics. Split in the mutant Meckel’s cartilage is shown
(arrowhead in F). Scale bars5 0.5mm (A–D) and 0.1mm (E,F).
Fig. 6 Immuno-histochemical detection of Hoxa2, Sox9, and Fgfr3
expression on sagittal sections of the lumbar column of Col2a1/
Hoxa2-lacZ double transgenics and bS-Hoxa2-lacZ littermates at
E13.5. (A) Negative immunostaining in a bS-Hoxa2-lacZ embryo.
The framed area corresponds to the regions illustrated in B–G. In
each case, bS-Hoxa2-lacZ transgenics (B,D,F) showed the same
phenotype as wild-type littermates. (B,C) Hoxa2 is only detected in
Col2a1/Hoxa2-lacZ transgenics (C) where it localizes mainly at the
periphery of the differentiating condensations (arrow). (D,E) Sox9
and (F,G) Fgfr3 are detected in differentiated chondrocytes
(arrows) in both Col2a1/Hoxa2-lacZ and bS-Hoxa2-lacZ litter-
mates. Scale bars5 50 mm.
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tion, detection of both Fgfr3 and Sox9 was equally
limited to those restricted cartilaginous areas (n5 2;
Figs. 6E,6G), thereby suggesting that the down-
regulatory effect of Hoxa2 on cartilage differentiation
takes place upstream of both these chondrogenic
players.
Altogether, our results indicate that persistent Hoxa2
expression in precartilaginous primordia impairs the
very initial chondrogenic differentiation process and
that chondrogenic precursors, whatever their NC,
paraxial, or lateral mesoderm origin, are equally
affected. This global impairment of differentiation
would not result from a direct inhibition of Sox9
expression but rather grounds upstream of the stimu-
latory FGF signaling occurring at the onset of the
chondrogenic program.
The Hoxa2-induced impairment of chondrogenesis does
not affect further ossification
As already mentioned, the surviving double transgenics
appear smaller than the unaffected simple transgenic or
WT littermates. This difference was progressively
marked after birth and appeared the most apparent
by postnatal day 5 (vertex-sacrum size: double mutants
to control ratio of 0.78  0.07; n5 4). The overall size
difference between double transgenics and control
animals could be correlated to size differences in
equivalent vertebrae. The height of nine vertebrae
(C2–C4, T5–T7, and L3–L5) of double transgenics
was measured 1 day after birth and on the day of their
death (postnatal days 5, 28, 51, and 56) and compared
with those of control littermates at the same age. The
relative vertebral size was decreased in Hoxa2 expres-
sers as compared with controls (axial size ratio of
0.63  0.26; n5 12). This postnatal growth defect
caused by the expression of Hoxa2 in chondrocytes is
consistent with the differentiation defect observed at
fetal stages.
To address whether the impaired chondrogenesis was
followed by a deficit in ossification per se or not, BMD
was determined by pQCT in the C3, T6, and L4
vertebrae of those individuals for which the vertebral
sizes were compared. BMD of Col2a1/Hoxa2-lacZ
mutants did not appear significantly different from
control littermates (383.1  154.0mg/cm3 in double
mutants versus 312.9  104.6mg/cm3 in controls,
n5 12), providing evidence that the Hoxa2-mediated
chondrodysplasia did not affect the subsequent ossifica-
tion process as such.
Discussion
In the mouse, cartilages start to develop from mesench-
ymal condensations, while the expression of patterning
Hox genes expression turns off. This temporal sequence
of events underlies an unresolved functional link
between the fading down of Hox expression and the
onset of chondrocyte differentiation. In this study, we
generated transgenic mice that allow conditional Cre-
mediated ectopic and heterochronic expression of
Hoxa2. These mouse lines were used to investigate
why such a Hox gene needs to be down-regulated to
engage chondrogenic differentiation programs. To this
end, we induced Hoxa2 activity beyond the onset of
chondrocyte differentiation and analyzed the impact of
a sustained expression of Hoxa2 on cartilage develop-
ment. We therefore demonstrated that Hoxa2 activity
has a drastic down-regulatory effect on chondrocyte
differentiation, which results in chondrodysplasia of
NC, sclerotome, and lateral mesoderm-derived skeletal
elements.
Col2a1/Hoxa2-lacZ double transgenic mice show
reduced or malformed secondary palate, nasal capsule,
neurocranium, viscerocranium, otic capsule, vertebral
column, ribs, and limbs. The lacZ staining of precursor
cells expressing Col2a1 revealed that their distribution
was unaffected in the double mutants. Immunostaining
of proliferating cells at E15.5 further showed that
chondrocytic proliferation was also unaffected. How-
ever, alcian blue staining of early developing cartilage
supported that the chondrodysplasic phenotype can be
interpreted as resulting from an initial differentiation
failure. At E13.5, while WT embryos display a wide
cartilaginous skeleton, the most affected double mu-
tants lack axial skeleton structures but only show
occipital, cervical, distal ribs, or otic capsule rudiments.
As a possible consequence, at E15.5, the skeleton of the
affected individuals presents a severe maturation delay
during the hypertrophy, mineralization, and ossification
steps. Finally, ectopic Hoxa2 expression during chon-
drogenesis led to perinatal or early lethality for more
than one-third of the double transgenic individuals.
This variation in survival does not seem to reflect
differences in the level of the Hoxa2 expression upon
Cre-mediated recombination. Indeed, the semi-quanti-
tative estimate of Hoxa2 expression in double trans-
genic E13.5 embryos did not reveal gross variation in
Hoxa2 expression level. Rather, the susceptibility to
early lethality may be due to the relative genetic
heterogeneity of the offsprings of crossings between
Col2a1-Cre and bS-Hoxa2-lacZ lines. In fact, these
transgenes have been maintained in distinct, C57BL/
6xSJL hybrid (Ovchinnikov et al., 2000) and FVB
inbred genetic backgrounds, respectively.
Previously reported ectopic and sustained expression
of Hoxa2 led to distinct phenotypes according to the
cell populations that were targeted for Hoxa2 mis-
expression and to the experimental design leading to
different timing and persistence of Hoxa2 expression.
Some ectopic activation of Hoxa2 resulted in patterning
modifications but did not give rise to differentiation
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defects as such (Grammatopoulos et al., 2000; Pasqua-
letti et al., 2000). Other misexpression experiments did
not lead to homeotic transformations (Grammatopou-
los et al., 2000; Creuzet et al., 2002), but rather to a
deficit in skeletal development. As previously discussed
(Grammatopoulos et al., 2000; Pasqualetti et al., 2000;
Creuzet et al., 2002), the different outcomes of Hoxa2
misexpression might reflect that in some instances, both
NC cells and branchial arch host tissue were targeted
while in others, Hoxa2 was only misexpressed in the
NC. However, critical differences between these experi-
ments also reside in that Hoxa2 misexpression was
either transient or sustained.
Although our data parallel those obtained when only
the NC cells were targeted to express Hoxa2 ectopically
(Grammatopoulos et al., 2000; Creuzet et al., 2002),
these experiments should be compared cautiously. In
the work presented here, the timing of Hoxa2 mis-
expression and the cellular population that ectopically
expressed this gene were clearly different from the
previously reported experiments. In fact, by inducing
Hoxa2 expression in Col2a1-expressing cells, NC and
branchial arches are allowed to be normally patterned.
Hoxa2 was thus precisely misexpressed only in cells that
are normally committed to enter chondrogenesis and
only at the precise stage chondrocyte differentiation
goes on. This implies that not only the skeletogenic NC
but also other skeletogenic compartments, i.e., paraxial
and lateral plate mesoderm, were targeted and consis-
tently showed chondrodysplasia. Altogether, our results
therefore show that on a cell-autonomous basis, Hoxa2
persistent expression delays chondrocyte differentiation,
by acting just upstream of a common basic chondro-
genic program. As the selective down-regulation of the
chondrogenic cascade occurs after migration of the
precursors, Hoxa2 is proposed to fulfill distinct but yet
related roles during skeletal development. It could not
only prevent the expression of some BA1-specific
patterning genes, like Lhx6 or Ptx1, in BA2 structures
(Bobola et al., 2003) but also impede premature
chondrogenesis of these structures.
While patterning defects were observed in the Hoxa2
loss of function, no precocious skeletal differentiation
or maturation was reported. This suggests that, in the
absence of Hoxa2, early differentiation or maturation
of incorrectly patterned structures or normal skeletal
elements is kept under control of redundant modulators
of chondrogenesis. In this regard, inactivation of the
Pbx1 gene coding for a key cofactor of Hox proteins
resulted in premature cartilage maturation and ossifica-
tion (Selleri et al., 2001). This indicates that the
activity of other down-regulators of chondrocyte
differentiation, like that of Hoxa2, relies on a partner-
ship with Pbx1. Finally, AP-2 factors are required to
provide Hoxa2 expression in the skeletogenic NC
(Maconochie et al., 1999). Interestingly, AP-2a was
recently shown to inhibit chondrogenesis in ATDC5
cells (Huang et al., 2004), which probably involves
Hoxa2 as a target to mediate this anti-skeletogenic
effect in vivo.
Extension of the Sox9 expression domains into
Hoxa2 / skeletogenic territories has been reported
and the forced expression of Sox9 under the control of
the Hoxa2 promoter partially phenocopied the Hoxa2
KO (Kanzler et al., 1998). Sox9 was thus proposed to
be negatively regulated by Hoxa2. Consistently, similar
chondrodysplasia with split Meckel’s cartilage was
found in Sox9 haploinsufficient mice (Bi et al., 2001)
and complete inactivation of a floxed Sox9 allele in the
limbs from the onset of differentiation blocked the
chondrogenic cascade (Akiyama et al., 2002). Here, we
show that in Col2a1/Hoxa2-lacZ mutant skeletons,
Sox9 and Fgfr3 expression domains are reduced. As
Fgfr3 has been shown to stimulate Sox9 expression
(Murakami et al., 2000), Hoxa2 could affect chondro-
genesis by modulating the expression of Fgfr3. In
addition, preliminary real-time PCR data (unpublished
results) indicate higher Sox9 expression rates at birth in
Col2a1/Hoxa2-lacZ cartilages as compared with bS-
Hoxa2-lacZ. This might reflect the observed delay in
chondrocyte differentiation and cartilage maturation, as
Sox9 expression has been shown to decrease during the
maturation process (Ng et al., 1997). Altogether, these
data argue against a direct inhibition of Sox9 expression
by Hoxa2 but rather, as was previously suggested for
patterning events (Abzhanov et al., 2003; Bobola et al.,
2003), for a negative interference of Hoxa2 on the BMP
and FGF pro-chondrogenic signaling cascades (Iimura
et al., 1994; Murtaugh et al., 1999; Carlberg et al., 2000;
Murakami et al., 2000; Zeng et al., 2002). This
interference could thus impair chondrogenesis and
delay cartilaginous maturation, eventually leading to a
prolonged Sox9 expression.
Bapx1 (Nkx3.2) is an important modulator of the
BMP signaling cascade. Bapx1 / mice (Triboli and
Lufkin, 1999) resemble Col2a1/Hoxa2-lacZ mutants:
they lack correctly shaped vertebral bodies, bony
basihyoid, and supraoccipital due to chondrogenesis
failure and they display altered Fgfr3 and Bmp4
expression patterns. In addition, Bapx1 was shown to
induce Sox9 expression by mediating the Shh-depen-
dent response of the prechondrogenic mesoderm to
BMP signals (Zeng et al., 2002). Moreover, the Xenopus
Bapx1 homolog is down-regulated in BA1 following a
targeted XHoxa2 gain of function (Pasqualetti et al.,
2000), suggesting that decreased Bapx1 activity may
also be involved in the Hoxa2-mediated impairment of
chondrogenesis.
Another important finding is that not only endo-
chondral structures but also some membranous bones
were affected in Col2a1/Hoxa2-lacZ transgenics. The
pterygoid and tympanic ring as well as the whole face
were reduced, contrary to what occurs in Col2a1 KO
mice in which only cartilaginous matrix deposition is
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affected (Li et al., 1995). This could result from
perturbed interactions between growing membranous
bones and the adjacent cartilages or from a direct
inhibition of membranous ossification following trans-
gene activation into the dermis as suggested by a
previous study (Kanzler et al., 1998). The unexpected
Col2a1-Cre expression in the dermis that presumably
results in the crumpled skin of double transgenics
newborns is supposed to arise from the ectopic
activity of the Col2a1 promoter fragment contained
in the Col2a1-Cre transgene. Ectopic activity of
integrated transgenes is a commonly observed phenom-
enon. It is worth noticing that another Col2a1-Cre
transgenic line has been generated by Sakai et al. (2001)
for which nonchondrocytic Cre expression was also
reported.
Is the anti-skeletogenic activity specific ofHoxa2 or is
it a common property of the entire Hox family?
Overexpression of Hoxd4 and Hoxc8 in their own
expression domains resulted in a closely similar
chondrodysplasia due to an accumulation of proliferat-
ing chondrocytes with no further hypertrophic differ-
entiation (Yueh et al., 1998). Hoxc8 was further shown
to mediate the BMP-induced osteoblastic differentiation
through cooperation with Smad1, an early effector of
BMPs, and to participate to the Smad6-dependent
negative feed-back loop on BMP signaling (Bai et al.,
2000). This has to be paralleled with the observation
that mice lacking Pbx1 exhibit premature differentia-
tion and maturation of cartilages, while no Hox loss
of function displayed such a phenotype. This points
toward a possible redundancy in the shared ability
of Hox proteins to restrain early chondrogenic differ-
entiation.
In conclusion, forcing the expression of Hoxa2 to
persist at a stage of chondrogenesis in which it should
be normally switched off led to severe chondrodysplasia
in transgenic mice. By inducing the conditional expres-
sion of Hoxa2 at the onset of chondrocyte differentia-
tion, we demonstrated that, independently of its role in
patterning and shaping bones, this gene, presumably
like other Hox genes, keeps chondrogenic differentia-
tion under control from its beginning. We therefore
propose that Hoxa2 expression is required up to a stage
precursor cells assemble in condensations and have to
remain undifferentiated, while later on, differentiation
and maturation of cartilage occurring, Hoxa2 needs to
be silenced.
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